Form 4: Teradyne Director Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Teradyne Director Mercedes Johnson reported the sale of 625 shares of common stock for $200 per share, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Mercedes Johnson, a Director of Teradyne, Inc. (TER), reported a transaction involving the company's common stock.
- On December 5, 2025, Johnson disposed of 625 shares of common stock at a price of $200 per share.
- The sale was conducted pursuant to a Rule 10b5-1 sales plan adopted on February 3, 2025.
- Following this transaction, Johnson directly beneficially owns 8,863 shares of common stock.
- Additionally, 1,876 shares are indirectly beneficially owned by The Mercedes Johnson Trust UAD 07/23/04, for which Johnson is the trustee and sole beneficiary.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a routine, pre-planned insider stock sale under a 10b5-1 plan, which is generally not indicative of a strong positive or negative sentiment regarding the company's prospects.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Mercedes Johnson, a director, sold 625 shares of Teradyne common stock.
- Additionally, 1,876 shares are held indirectly by The Mercedes Johnson Trust UAD 07/23/04, of which the Reporting Person is the trustee and sole beneficiary.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, pre-planned sale of a relatively small number of shares by a director.
Key Dates
| Date | Description |
|---|---|
| 2004-07-23 | Date of The Mercedes Johnson Trust UAD |
| 2025-02-03 | Date Reporting Person adopted the Rule 10b5-1 sales plan |
| 2025-12-05 | Transaction date for the sale of common stock |
| 2025-12-08 | Filing date of the Form 4 |
Keywords
Teradyne, TER, Mercedes Johnson, Insider Trading, Stock Sale, Form 4, 10b5-1 Plan, Director Transaction, Equity Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.